Navigation Links
Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
Date:11/21/2008

ans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements concerning new products, potential regulatory approvals, and customer adoption are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to: (i) the risk that our APTIMA HPV assay will perform poorly in its US clinical trial, (ii) the risk that the APTIMA HPV assay will not be cleared for marketing in the timeframe we expect, if at all, (iii) the chance that additional studies of our APTIMA HPV assay may not confirm the results discussed here, (iv) the possibility that the market for the sale of our APTIMA HPV assay may not develop as expected, (v) we may not be able to compete effectively with other companies already selling HPV diagnostic products or which launch such products in the future, (vi) we depend on a small number of contract manufacturers and single source suppliers of raw materials, (vii) changes in third-party reimbursement policies regarding our products could adversely affect their sales, (viii) changes in government regulation affecting our products could harm our sales and increase our development costs, and (ix) litigation involving the assertion of third party patent rights could be expensive and divert management's attention, and/or result in damag
'/>"/>
SOURCE Gen-Probe
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
2. Promising Data ATIR Studies Presented by NIH Investigators
3. Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer
4. Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
5. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
6. Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008
7. AMDL ELISA DR-70(R) (FDP) is Promising as Effective Cancer Detection Test
8. PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet
9. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  Renova™ Therapeutics, a ... heart failure and other chronic diseases, has engaged ... analysis designed to reflect the healthcare patterns of ... model will be used to characterize the impact ... have on those groups of patients and the ...
(Date:5/5/2015)... , May 5, 2015 ImmunoCellular Therapeutics, ... Andrew Gengos , President and Chief Executive Officer, ... 2015. DATE:  Thursday, May 7, 2015     ... http://VirtualInvestorConferences.com > click the red "register/ watch ... live, interactive online event where investors are invited ...
(Date:5/5/2015)... May 05, 2015 A comment period ... wide range of key photonics technologies – regulations that ... of U.S. industry. To help the community understand and ... May on the proposed changes to U.S. Munitions ... by International Traffic in Arms Regulations (ITAR). , For ...
(Date:5/5/2015)... DUBLIN , May 05, 2015 Research ... announced the addition of the "Clinical Laboratory, ... and Forecast 2015 to 2019 - Global Version" ... technical developments especially in the area of molecular ... dynamic, growing and evolving world market that is ...
Breaking Biology Technology:RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7 2Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2
... , , , PRINCETON, ... Company) (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced ... Officer, will present at the Rodman & Renshaw 11th Annual ... at 4:55 PM on Thursday, September 10, 2009 in the ...
... - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that ... , , - Rodman & Renshaw 11th ... September 10, 2009 at 12:30 p.m. Eastern Time in the Fahnestock Salon, ... Hotel in New York City., - Thomas ...
... 2 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Robert W. Baird & Co. 2009 Health Care Conference ... 2009 Health Care Conference in New York, New York, on September 9, 2009 ... Thomas Weisel Partners Healthcare Conference , Subsequently, Onyx will ...
Cached Biology Technology:DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 2DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 3DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 4OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences 2Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences 2
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
(Date:4/1/2015)... Conn. , Apr. 1, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... of Wocket smart wallets is underway to early access ... access group includes usage at retail outlets including Walmart, ... Pharmacy. Users report Wocket was accepted at all outlets ...
(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications Corp. ... global provider of Software Defined Network Architecture (ET Software ... total revenue of approximately $20.4 million for the year ... $19.5 million for the year ended December 31, 2013. ... the Company had completed its multi-year transition away from ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... built at Scripps Institution of Oceanography at UC San ... state of all world oceans simultaneously is approaching its ... network of sensor-bearing profiling floats measures ocean water temperature, ... The Argo Steering Committee, the international panel of scientists ...
... living and dead organisms could serve as a relatively fast, ... ecosystems. The University of Chicago,s Susan Kidwell explains how measuring ... ecological tool in the Oct. 26 early online edition of ... affect ecosystems in many different ways, but the effects of ...
... and their colleagues have uncovered evidence of when Earth ... the one we breathe today. The study suggests ... of reverse-greenhouse effect 500 million years ago that cooled ... a burst of oxygen into the atmosphere. That ...
Cached Biology News:Unprecedented global measurement network achieves full coverage of oceans 2Unprecedented global measurement network achieves full coverage of oceans 3Dead clams tell many tales 2Dead clams tell many tales 3Dead clams tell many tales 4Researchers find origin of 'breathable' atmosphere half a billion years ago 2Researchers find origin of 'breathable' atmosphere half a billion years ago 3Researchers find origin of 'breathable' atmosphere half a billion years ago 4
... recognizes murine IRF7 protein, and ... related IRF proteins. Reactivity of ... protein was confirmed by western ... cells transfected with IRF7. Reactivity ...
...
EMBP (FL-222)...
Rabbit anti-T-box 6...
Biology Products: